BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8539644)

  • 1. Magnetic resonance imaging of focal liver lesions.
    Schnall M
    Semin Roentgenol; 1995 Oct; 30(4):347-61. PubMed ID: 8539644
    [No Abstract]   [Full Text] [Related]  

  • 2. Technique for MR imaging of the liver.
    Saini S; Nelson RC
    Radiology; 1995 Dec; 197(3):575-7. PubMed ID: 7480718
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver MR imaging: 1.5T versus 3T.
    Ramalho M; Altun E; Herédia V; Zapparoli M; Semelka R
    Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):321-47, vi. PubMed ID: 17893053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
    Quillin SP; Atilla S; Brown JJ; Borrello JA; Yu CY; Pilgram TK
    Magn Reson Imaging; 1997; 15(3):275-85. PubMed ID: 9201674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of the liver: comparison between single-shot echo-planar and half-Fourier rapid acquisition with relaxation enhancement sequences.
    Yamashita Y; Tang Y; Namimoto T; Mitsuzaki K; Takahashi M
    Radiology; 1998 May; 207(2):331-7. PubMed ID: 9577477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
    Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
    Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diffusion-weighted MR imaging of the liver].
    Vilgrain V; Daire JL; Sinkus R; Van Beers BE
    J Radiol; 2010 Mar; 91(3 Pt 2):381-90; quiz 391-3. PubMed ID: 20508573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath-hold T2-weighted MRI of hepatic tumors: value of echo planar imaging with diffusion-sensitizing gradient.
    Okada Y; Ohtomo K; Kiryu S; Sasaki Y
    J Comput Assist Tomogr; 1998; 22(3):364-71. PubMed ID: 9606375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of the liver using gadolinium chelates.
    Low RN
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging.
    Elsayes KM; Narra VR; Yin Y; Mukundan G; Lammle M; Brown JJ
    Radiographics; 2005; 25(5):1299-320. PubMed ID: 16160113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophilic hepatic necrosis: magnetic resonance imaging and computed tomography comparison.
    Yu JS; Yoon SW; Park MS; Lee JH; Kim KW
    J Comput Assist Tomogr; 2005; 29(6):765-71. PubMed ID: 16272849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
    Ba-Ssalamah A; Happel B; Kettenbach J; Dirisamer A; Wrba F; Längle F; Schima W
    Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future.
    Naganawa S; Kawai H; Fukatsu H; Sakurai Y; Aoki I; Miura S; Mimura T; Kanazawa H; Ishigaki T
    Magn Reson Med Sci; 2005 Dec; 4(4):175-86. PubMed ID: 16543702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal liver lesion detection and characterization: comparison of non-contrast enhanced and SPIO-enhanced diffusion-weighted single-shot spin echo echo planar and turbo spin echo T2-weighted imaging.
    Coenegrachts K; Matos C; ter Beek L; Metens T; Haspeslagh M; Bipat S; Stoker J; Rigauts H
    Eur J Radiol; 2009 Dec; 72(3):432-9. PubMed ID: 18849130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of focal liver lesions: the 90 %-rule.
    Mostbeck G
    Ultraschall Med; 2010 Dec; 31(6):545-7. PubMed ID: 21117006
    [No Abstract]   [Full Text] [Related]  

  • 20. Focal liver lesions detection: Comparison of respiratory-triggering, triggering and tracking navigator and tracking-only navigator in diffusion-weighted imaging.
    Bouchaibi SE; Coenegrachts K; Bali MA; Absil J; Metens T; Matos C
    Eur J Radiol; 2015 Oct; 84(10):1857-65. PubMed ID: 26119802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.